Wall Street is positive on Agile Therapeutics Inc (AGRX). On average, analysts give AGRX a Buy rating. The average price target is $126.666, which means analysts expect the stock to increase by 18257.39% over the next twelve months. That average ranking earns AGRX an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating AGRX a Buy today. Find out what this means to you and get the rest of the rankings on AGRX!